The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chukhlovina M.L.

Almazov National Medical Research Center

Polyneuropathies during COVID-19 epidemics

Authors:

Chukhlovina M.L.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(5): 138‑143

DOI: 10.17116/jnevro2021121051138

Read: 5654 times

Download PDF (RU)
Contact the author
Table of contents

POLYNEUROPATHIES DURING COVID-19 EPIDEMICS
POLYNEUROPATHIES DURING COVID-19 EPIDEMICS

To cite this article:

Chukhlovina ML. Polyneuropathies during COVID-19 epidemics. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(5):138‑143. (In Russ.)
https://doi.org/10.17116/jnevro2021121051138

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pote­ntial of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Painful diabetic poly­neuropathy in patients with cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):64-72
Coca­rnit in complex therapy of diabetic peri­pheral poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):73-81
Algo­rithm for the diagnosis and treatment of patients with diabetic poly­neuropathy. Expert Council Reso­lution (March 1, 2025). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):102-113
Labo­ratory tests for diagnostics of cell immu­nity against SARS-CoV-2 (review of lite­rature). Labo­ratory Service. 2024;(3):31-36
Deve­lopment and testing of the first dome­stic auto­matic cartridge-type POCT platform for the qualitative dete­rmination of SARS-CoV-2 RNA. Labo­ratory Service. 2024;(4):21-27
Post-Covid aortitis with cardiac invo­lvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58
Abstract:

Our review article aimed for analysis of pathogenesis, diagnostyics and treatment of polyneuropathies manifesting in the course of COVID-19. The reasons for hyposmia and taste disturbances are considered in the subjects with this coronavirus infection as well as relationship between these clinical manifestations and severity of the viral infection. Special attention is given to description of autoimmune mechanisms of Guillain-Barré syndrome and polyneuropathies of critical conditions associated with COVID-19. Some data report about clinical deterioration of diabetic and alcoholic neuropathy during the SARS-CoV-2 infection. Inclusion of group B vitamins, together with C and D vitamins, is recommended to the schedules of combined treatment for polyneuropathies in these patients. Early diagnostics of polyneuropathies, especially, Guillain-Barré syndrome, is required during COVID-19 pandemics, thus helping to administer rational therapy and promoting better quality of life in the patients.

Keywords:

SARS-CoV-2
Guillain-Barré syndrome
diabetic neuropathy
alcoholic neuropathy
Neuromultivit

Authors:

Chukhlovina M.L.

Almazov National Medical Research Center

Received:

03.03.2021

Accepted:

11.03.2021

Close metadata

References:

  1. Gusev EI, Martynov MYu, Boyko AN, Voznyuk IA, Lashch NYu, Sivertseva SA, Spirin NN, Shamalov NA. Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):7-16. (In Russ.). https://doi.org/10.17116/jnevro20201200617
  2. Rider FK, Lebedeva AV, Mkrtchyan VR, Guekht AB. Epilepsy and COVID-19: patient management and optimization of antiepileptic therapy during pandemic. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(10):100-107. (In Russ.). https://doi.org/10.17116/jnevro2020120101100
  3. Ivanova GE, Melnikova EV, Levin OS, Khatkova SE, Khasanova DR, Yanishevsky SN, Daminov VD, Vasenina EE, Gurkina MV. Current issues in the Rehabilitation of stroke patients against the background of a new coronavirus infection (COVID-19). Resolution of the council of experts. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(8-2):81-87. (In Russ.). https://doi.org/10.17116/jnevro202012008281
  4. Putilina MV, Vechorko VI, Grishin DV, Sidelnicova LV. Acute cerebrovascular accidents associated with SARS-COV-2 coronavirus infection (COVID-19). S.S. Korsakov Journal of Neurology and Psychiatry. 2020; 120(12):109-117. (In Russ.). https://doi.org/10.17116/jnevro2020120121109
  5. Keller E, Brandi G, Winklhofer S, Imbach LL, Kirschenbaum D, Frontzek K, La Steiger P, Dietler S, Haeberlin M, Willms J, Porta F, Waeckerlin A, Huber M, Abela IA, Lutterotti A, Stippich C, Globas C, Varga Z, Jelcic I. Lrge and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series. Stroke. 2020;51(12):3719-3722. https://doi.org/10.1161/STROKEAHA.120.031224
  6. Lechien JR, Chiesa-Estomba CM, De Siati DR, Bon SD, Rodriguez A, Dequanter D, Blecic S, Afia FE, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez Lavigne CP, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis AC, Coppee F, Fakhry N, Ayad T, Saussez S. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8): 2251-2261.
  7. Nouchi A, Chastang J, Miyara M, Lejeune J, Soares A, Ibanez G. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2020;10:1-7.  https://doi.org/10.1007/s10096-020-04056-7
  8. Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103-1104. https://doi.org/10.1002/alr.22593
  9. Printza A, Constantinidis J. The role of self-reported smell and taste disorders in suspected COVID-19. Eur Arch Otorhinolaryngol. 2020; 277(9):2625-2630. https://doi.org/10.1007/s00405-020-06069-6
  10. Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020;95(8):1621-1631. https://doi.org/10.1016/j.mayocp.2020.05.030
  11. Hopkins C, Alanin MC, Harries P, Whitcroft K, Qureishi A, Anari S, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic — BRS Consensus Guidelines. Clin Otolaryngol. 2021;46(1):16-22.  https://doi.org/10.1111/coa.13636
  12. Piradov MA. Guillain-Barré syndrome. M.: Intermedika; 2003. (In Russ.).
  13. Leonhard SE. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671-683. 
  14. Finsterer J, Scorza FA, Fiorini AC. SARS-CoV-2-associated Guillain-Barré syndrome in 62 patients. Eur J Neurol. 2021;28(1):10-12.  https://doi.org/10.1111/ene.14544
  15. Manganotti P, Bellavita G, D’Acunto L, Tommasini V, Fabris M, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol. 2021;93(2): 766-774.  https://doi.org/10.1002/jmv.26289
  16. Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19:102597. https://doi.org/10.1016/j.autrev.2020.102597
  17. Lucchese G, Flöel A. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020;25:731-735.  https://doi.org/10.1007/s12192-020-01145-6
  18. Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience. Muscle Nerve. 2020;62(4):485-491.  https://doi.org/10.1002/mus.27024
  19. Espíndola OM, Brandão CO, Gomes YCP, Siqueira M, Soares CN, Lima MAS. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int J Infect Dis. 2021;102:155-162.  https://doi.org/10.1016/j.ijid.2020.10.044
  20. Davidov NR, Vinogradov OI, Gorokhovatsky YuI, Kuznetsov AN. Polyneuropathy of Critical Conditions: Causes, Diagnosis, Management and Preventive Approaches. Neurological Journal. 2016;21(1):48-55. (In Russ.).
  21. McClafferty B, Umer I, Fye G, Kepko D, Kalayanamitra R, Shahid Z, Ramgobin D, Cai A, Groff A, Bhandari A, Aggarwal CS, Patel R, Bhatt D, Polimera H, Sahu N, Vunnam R, Golamari R, Kumar A, Jain R. Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients. J Clin Neurosci. 2020;79:241-245.  https://doi.org/10.1016/j.jocn.2020.07.058
  22. Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, Steinbrenner M, Angermair S, Treskatsch S, Zickler D, Eckardt K-U, Dersch R, Hosp J, Audebert HJ, Endres M, Ploner JC, Prüß H. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021 Mar;93:415-419. Available online 24 December 2020. https://doi.org/10.1016/j.bbi.2020.12.022
  23. Levin OS. Polyneuropathy. Manual for doctors. M.: Meditsinskoe informatsionnoe agentstvo; 2016:486. (In Russ.).
  24. Patel K, Horak H, Tiryaki E. Diabetic neuropathies. Muscle Nerve. 2021; 63(1):22-30.  https://doi.org/10.1002/mus.27014
  25. Azmi S, Alam U, Burgess J, Malik RA. State-of-the-art pharmacotherapy for diabetic neuropathy. Expert Opin Pharmacother. 2021;22(1):55-68.  https://doi.org/10.1080/14656566.2020.1812578
  26. Yang Y, Zhong W, Tian Y, Xie C, Fu X, Zhou H. The effect of diabetes on mortality of COVID-19. Medicine (Baltimore). 2020;99(27):e20913. https://doi.org/10.1097/MD.0000000000020913
  27. Odriozola A, Ortega L, Martinez L, Odriozola S, Torrens A, Corroleu D, Martínez S, Ponce M, Meije Y, Presas M, Duarte A, Odriozola MB, Malik RA. Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection. Diabetes Res Clin Pract. 2020;172:108631. https://doi.org/10.1016/j.diabres.2020.108631
  28. Cariou B, Hadjadj S, Wargny M. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500-1515.
  29. Chen D, Zhou H, Yang Y, Chunguang YZ, Jaly X The adverse effects of novel coronavirus on diabetic foot patients: A protocol for systematic review and meta analysis. Medicine (Baltimore). 2020;99(43):e22758. https://doi.org/10.1097/MD.0000000000022758
  30. Jaly I, Iyengar K, Bahl S, Hughes T, Vaishy R. Redefining diabetic foot disease management service during COVID-19 pandemic. Diabetes Metab Syndr. 2020;14(5):833-838.  https://doi.org/10.1016/j.dsx.2020.06.023
  31. Chukhlovina ML, Chukhlovin A.A. Clinical manifestations and treatment of diabetic polyneuropathy in elderly patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(6):42-46. (In Russ.). https://doi.org/10.17116/jnevro20191190642
  32. Kamchatnov PR, Kabanov AA, Khanmurzaeva SB, Chugunov AV, Khanmurzaeva NB. The use of carnitine in patients with diabetic polyneuropathy. Consilium Medicum. 2017;2:136-140. (In Russ.).
  33. Savlovskaya OA. Neurotropic effect of B vitamins in the complex treatment of pain syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(9):118-123. (In Russ.). https://doi.org/10.17116/jnevro201711791118-123
  34. Jovic TH, Ali SR, Ibrahim N, Jessop ZM, Tarassoli SP, Dobbs TD, Holford P, Thornton CA, Whitaker IS. Could Vitamins Help in the Fight Against COVID-19? Nutrients. 2020;12(9):2550. https://doi.org/10.3390/nu12092550
  35. Tan CH, Ho LP, Kalimuddin S, Cherng BP, Teh YE, Thien SY, Wong HM, Paul Jie Wen Tern PJ, Manju Chandran M, Chay JWM, Nagarajan C, Sultana R, Low JGH, Ng HJ. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020;(1):79-80:111017. https://doi.org/10.1016/j.nut.2020.111017
  36. Wee AKH. COVID-19’s toll on the elderly and those with diabetes mellitus — Is vitamin B12 deficiency an accomplice? Med Hypotheses. 2021; 146(1):110374. https://doi.org/10.1016/j.mehy.2020.110374
  37. Islam MT, Quispe C, Martorell M, Anca Oana Docea AO, Salehi B, Calina D, Reiner Z, Sharifi-Rad J. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19. Int J Vitam Nutr Res. 2021;1:1-18.  https://doi.org/10.1024/0300-9831/a000694
  38. Calderon-Ospina C-A, Nava-Mesa MO, Ariza CEA. Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Meta-analysis. Pain Med. 2020;21(4):766-781.  https://doi.org/10.1093/pm/pnz216
  39. Zhang D, Yang W, Wang C, Zheng H, Liu Z, Chen Z, Gao C. Methylcobalamin-Loaded PLCL Conduits Facilitate the Peripheral Nerve Regeneration. Macromol Biosci. 2020;20(3):e1900382. https://doi.org/10.1002/mabi.201900382
  40. Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J Neurol. 2019;266(12):2907-2919. https://doi.org/10.1007/s00415-018-9123-1
  41. Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. COVID-19 and addiction. Diabetes Metab Syndr. 2020;14(5):817-823.  https://doi.org/10.1016/j.dsx.2020.06.008
  42. Clay JM, Parker MO. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health. 2020;5(5):e259. https://doi.org/10.1016/S2468-2667(20)30088-8
  43. Ramalho R. Alcohol consumption and alcohol-related problems during the COVID-19 pandemic: a narrative review. Australas Psychiatry. 2020; 28(5):524-526.  https://doi.org/10.1177/1039856220943024
  44. Pressman P, Clemens R, Sahu S, Hayes AW. A review of methanol poisoning: a crisis beyond ocular toxicology. Cutan Ocul Toxicol. 2020;39(3):173-179.  https://doi.org/10.1080/15569527.2020.1768402
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.